Newborn Pulse Oximetry Screening for Detecting Congenital Heart Disease: Experience at a Tertiary Care Center
- PMID: 38250570
- PMCID: PMC10796186
- DOI: 10.1155/2024/3279878
Newborn Pulse Oximetry Screening for Detecting Congenital Heart Disease: Experience at a Tertiary Care Center
Abstract
Background: Congenital heart disease (CHD) remains the number one birth defect worldwide. Pulse oximetry screening (POS) is a widely used CHD screening modality effective in detecting critical lesions. This study is aimed at assessing the accuracy and cost-effectiveness of POS in a cohort of term well-babies admitted to a regular nursery in a tertiary care center.
Methods: We reviewed the charts of term babies admitted to our regular nursery over a period of one year. The results of POS and the findings of echocardiography were collected. Similarly, we explored the records of our fetal echocardiography program to identify the fetuses screened for CHD during the same period.
Results: 900 term babies were born and admitted to newborn nursery at our center, and 69 fetuses were evaluated by our fetal cardiology team during the study period. None of our term babies had a positive POS at birth or 24 hours of age. However, 56 babies had a cardiac echo before hospital discharge due to suspicious findings on physical examination or a family history of CHD. A simple noncritical CHD was noted in 10 of them. Additionally, 53 babies underwent echocardiography within the first five years of life; a simple CHD was noted in 6 of them. In parallel, 21 of our fetuses were found to have CHD: 16 simple CHD and 5 critical CHD (CCHD).
Conclusion: Despite its cost-effectiveness and efficacy in screening for CCHD, POS is suboptimal for detecting simple CHD. In the absence of a proper prenatal screening and fetal echocardiography program, POS remains a cost-effective modality for detecting CCHD.
Copyright © 2024 Ziad R. Bulbul et al.
Conflict of interest statement
The authors declare that they have no conflicts of interest.
Figures



Similar articles
-
Pulse oximetry screening for critical congenital heart disease: a comparative study of cohorts over 11 years.J Matern Fetal Neonatal Med. 2020 Jun;33(12):2064-2068. doi: 10.1080/14767058.2018.1538348. Epub 2019 Jan 4. J Matern Fetal Neonatal Med. 2020. PMID: 30332903
-
An update work of pulse oximetry screening for detecting critical congenital heart disease in the newborn.Images Paediatr Cardiol. 2017 Jul-Sep;19(3):12-18. Images Paediatr Cardiol. 2017. PMID: 29731786 Free PMC article.
-
Can echocardiographic screening in the early days of life detect critical congenital heart disease among apparently healthy newborns?BMC Pediatr. 2018 Nov 19;18(1):359. doi: 10.1186/s12887-018-1344-z. BMC Pediatr. 2018. PMID: 30453920 Free PMC article.
-
Screening for Critical Congenital Heart Defects with Pulse Oximetry: Medical Aspects.Am J Perinatol. 2016 Sep;33(11):1062-6. doi: 10.1055/s-0036-1586110. Epub 2016 Sep 7. Am J Perinatol. 2016. PMID: 27603536 Review.
-
Canadian Cardiovascular Society/Canadian Pediatric Cardiology Association Position Statement on Pulse Oximetry Screening in Newborns to Enhance Detection of Critical Congenital Heart Disease.Can J Cardiol. 2017 Feb;33(2):199-208. doi: 10.1016/j.cjca.2016.10.006. Epub 2016 Oct 26. Can J Cardiol. 2017. PMID: 28043739 Review.
References
-
- Bitar F. F., Baltaji N., Dbaibo G., Abed el-Jawad M., Yunis K. A., Obeid M. Congenital heart disease at a tertiary care center in Lebanon. Middle East Journal of Anaesthesiology . 1999;15(2):159–164. - PubMed
LinkOut - more resources
Full Text Sources